Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PANOBINOSTAT vs PARICALCITOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PANOBINOSTAT vs PARICALCITOL: Safety Overview

Metric PANOBINOSTAT PARICALCITOL
Total FAERS Reports 1,820 6,665
Deaths Reported 517 4,801
Death Rate 28.4% 72.0%
Hospitalizations 623 1,662
Average Patient Age 61.8 yrs 57.8 yrs
% Female Patients 49.7% 43.1%
FDA Approval Date Feb 23, 2015 Apr 17, 1998
Manufacturer N/A Aurobindo Pharma Limited
Route N/A ORAL
Marketing Status Discontinued Prescription